Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Inmune Bio (INMB) has issued an announcement.
INmune Bio Inc. has recently granted their CEO, Ramond J. Tesi, an option to buy 37,882 shares at $8.72 each as part of their 2021 Stock Incentive Plan. This option became effective immediately and is set to expire on June 9, 2034, demonstrating the company’s confidence in their leadership and providing an incentive for continued success.
For detailed information about INMB stock, go to TipRanks’ Stock Analysis page.